Recombinant LILRA4 (Daxdilimab Biosimilar) antibody

Catalog No. ABIN7829320

This Humanized Monoclonal antibody specifically detects LILRA4 (Daxdilimab Biosimilar) . It exhibits reactivity toward Human.

Quick Overview for Recombinant LILRA4 (Daxdilimab Biosimilar) antibody (ABIN7829320)

Target: LILRA4 (Daxdilimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This LILRA4 (Daxdilimab Biosimilar) antibody is un-conjugated

Grade: Research Grade

Product Details anti-LILRA4 (Daxdilimab Biosimilar) Antibody

Purpose: Anti-LILRA4(daxdilimab biosimilar) mAb

Isotype: IgG1

Application Details

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for LILRA4 (Daxdilimab Biosimilar)

Target: LILRA4 (Daxdilimab Biosimilar)

Alternative Name: Daxdilimab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:ILT7,CD85g
Synonyms Antibody:HZN-7734,HZN7734,MEDI-7734,MEDI7734,VIB-7734,VIB7734

UniProt: P59901